BRCA1 and breast carcinoma: However, BRCA1/2-associated breast cancer is accompanied by a defect of homologous recombination repair function, which may be more sensitive to DNA-damaging drugs, such as platinum drugs or poly-ADP ribose polymerase inhibitors.